Nephropathy in Type 2 Diabetes Mellitus
Diabetic kidney disease is chronic kidney damage associated with type 2 diabetes. It may appear as increased urine albumin, falling filtration function or both and often causes no symptoms until disease is advanced.
Key takeaways
- Regular urine albumin and eGFR testing can detect kidney involvement before swelling or reduced urine appears.
- Blood pressure, glucose and cardiovascular risk are managed together to slow progression.
- A sudden kidney-function change should not automatically be attributed to diabetes; obstruction, dehydration and medicines need review.
A kidney-protection listing cannot confirm diabetic nephropathy or define treatment; albumin, eGFR, potassium, blood pressure and other causes guide care.
How is diabetic kidney disease assessed?
Urine albumin-to-creatinine ratio and eGFR trends are central. Blood pressure, potassium, eye and nerve complications and cardiovascular disease add context. Blood or heavy protein in urine, rapid decline or an unusual pattern may prompt investigation for another kidney disease.
What can slow progression?
Irbesartan can reduce albuminuria and protect kidneys in selected patients but may raise potassium or creatinine. Glucose-lowering and other kidney-protective classes may also be relevant. Monitoring and heart and blood pressure management are essential.
When to seek urgent care
Seek urgent care for a sudden major drop in urine, severe breathlessness, rapidly increasing swelling, chest pain, confusion, persistent vomiting or profound weakness that may indicate acute kidney or potassium complications.